研究西药房高危药品管理问题及对策
|
摘要
目的探讨西药房高危药品管理中存在的问题,并针对性提出解决对策进行干预。方法从本院2017年2月至2018年2月西药房药品管理人员以及高危药品中,随机抽取9例药物管理人员与64种高危药品作为研究对象,分析高危药品管理中存在的问题,并提出对策进行管理干预。对比干预前后高危药品不良事件发生情况。结果警示牌不合格、摆放错误是导致高危药品不良事件的主要原因,干预后高危药品不良事件发生率显著低于干预前,差异具有统计学意义(P<0.05)。结论对西药房高危药品进行管理干预能够有效降低高危药品不良事件的发生几率,提高临床治疗的安全性。
Objective To explore the existing problems in the management of high-risk medicines in western pharmacies and to propose countermeasures for intervention.Methods 9 drug managers and 64 high-risk drugs were randomly selected from the drug managers and high-risk drugs in the Western pharmacy from February 2017 to February 2018 in this hospital as subjects to analyze the problems in high-risk drug management.And propose countermeasures for management intervention.The incidence of high-risk drug adverse events before and after the intervention was compared.Results The failure of warning signs and wrong placement were the main causes of high-risk drug adverse events.The incidence of high-risk drug adverse events after intervention was significantly lower than before the intervention,and the difference was statistically significant(P<0.05).Conclusion The management intervention of high-risk drugs in western pharmacy can effectively reduce the occurrence of high-risk drug adverse events and improve the safety of clinical treatment.
Objective To explore the existing problems in the management of high-risk medicines in western pharmacies and to propose countermeasures for intervention.Methods 9 drug managers and 64 high-risk drugs were randomly selected from the drug managers and high-risk drugs in the Western pharmacy from February 2017 to February 2018 in this hospital as subjects to analyze the problems in high-risk drug management.And propose countermeasures for management intervention.The incidence of high-risk drug adverse events before and after the intervention was compared.Results The failure of warning signs and wrong placement were the main causes of high-risk drug adverse events.The incidence of high-risk drug adverse events after intervention was significantly lower than before the intervention,and the difference was statistically significant(P<0.05).Conclusion The management intervention of high-risk drugs in western pharmacy can effectively reduce the occurrence of high-risk drug adverse events and improve the safety of clinical treatment.
引文
[1]韩成林.PDCA循环方法在我院高危药品管理中的应用[J].中国药房,2016,27(7):929-931.
[2]张永.PDCA循环管理方法应用于我院三级综合医院复审过程中药事管理的体会[J].中国药房,2016,27(10):1305-1307.
[3]李玉珍.基于追踪方法学的高危药品管理与持续改进[J].中国卫生质量管理,2016,23(3):20-23.
[4]袁伟丽.浅论西药房高危药品管理中存在的问题及解决措施[J].当代医药论丛,2016,14(17):6-7.
[5]张丽.高危药品在门诊药房管理中存在的问题和对策[J].中国药物经济学,2017,12(4):156-158.
[6]宋妍.浅析高危药品在门诊药房管理中存在的不足和解决措施[J].中国卫生产业,2016,13(12):176-178.
[7]宁红红.西药房高危药品的管理与用药安全分析[J].中国保健营养,2016,26(8):303-304.
[8]李敏.安全管理在西药房高危药品管理中的应用价值[J].中国药物经济学,2016,11(11):191-193.
[9]刘冀.安全管理在西药房高危药品管理中的应用价值[J].临床医药文献电子杂志,2017,4(42):8306-8307.
[10]霍结容.西药房高危药品的管理及用药安全的探讨[J].北方药学,2017,14(6):148-149.
[2]张永.PDCA循环管理方法应用于我院三级综合医院复审过程中药事管理的体会[J].中国药房,2016,27(10):1305-1307.
[3]李玉珍.基于追踪方法学的高危药品管理与持续改进[J].中国卫生质量管理,2016,23(3):20-23.
[4]袁伟丽.浅论西药房高危药品管理中存在的问题及解决措施[J].当代医药论丛,2016,14(17):6-7.
[5]张丽.高危药品在门诊药房管理中存在的问题和对策[J].中国药物经济学,2017,12(4):156-158.
[6]宋妍.浅析高危药品在门诊药房管理中存在的不足和解决措施[J].中国卫生产业,2016,13(12):176-178.
[7]宁红红.西药房高危药品的管理与用药安全分析[J].中国保健营养,2016,26(8):303-304.
[8]李敏.安全管理在西药房高危药品管理中的应用价值[J].中国药物经济学,2016,11(11):191-193.
[9]刘冀.安全管理在西药房高危药品管理中的应用价值[J].临床医药文献电子杂志,2017,4(42):8306-8307.
[10]霍结容.西药房高危药品的管理及用药安全的探讨[J].北方药学,2017,14(6):148-149.